Apriori Bio: Funding, Investors & Team (Oct 2026)
Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the entire landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants. Octavia can also inform public health policy in real time by predicting the impact of emerging variants. Apriori was founded in 2020 in Flagship Labs, a unit of Flagship Pioneering.
Apriori Bio has raised $1.1M across 1 funding round on record, the most recent an undisclosed round of $1.1M announced in Jul 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Apriori Bio Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Apriori Bio Funding Rounds
Apriori Bio Founders and Leadership Team
No contact details are on record for this team yet.
Apriori Bio Funding Compared to Other Biotechnology Startups
Apriori Bio's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Apriori Bio in Biotechnology and Boston
Companies Similar to Apriori Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Apriori Bio Funding FAQs
What does Apriori Bio do?
Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the entire landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants. Octavia can also inform public health policy in real time by predicting the impact of emerging variants. Apriori was founded in 2020 in Flagship Labs, a unit of Flagship Pioneering.
How much funding has Apriori Bio raised?
Apriori Bio has raised $1.1M across 1 round on record. The most recent is an undisclosed round of $1.1M announced in Jul 2024.
When did Apriori Bio last raise funding?
Apriori Bio's most recent funding round on record is an undisclosed round of $1.1M, announced in Jul 2024.
Who founded Apriori Bio?
FundedIQ lists Lovisa Afzelius (Founder) at Apriori Bio.
Where is Apriori Bio headquartered?
Apriori Bio is based in Boston, Massachusetts, United States.
How many employees does Apriori Bio have?
Apriori Bio is in the 11-50 employee band.
How does Apriori Bio's funding compare to other Biotechnology startups?
Apriori Bio's latest round of $1.1M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Apriori Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Apriori Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.